Nan K - Search Results

1

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma.

Xiang L, Fu X, Wang X, Li W, Zheng X, Nan K, Tian T. Xiang L, et al. Among authors: nan k. Front Oncol. 2020 Sep 24;10:559896. doi: 10.3389/fonc.2020.559896. eCollection 2020. Front Oncol. 2020. PMID: 33072585 Free PMC article.

2

[Research on resveratrol's mechanism of immunity in anti-aging].

Yao Y, Tian T, Nan KJ. Yao Y, et al. Zhong Yao Cai. 2006 May;29(5):464-7. Zhong Yao Cai. 2006. PMID: 16981461 Chinese.

3

Selenoprotein P mRNA expression in human hepatic tissues.

Li CL, Nan KJ, Tian T, Sui CG, Liu YF. Li CL, et al. World J Gastroenterol. 2007 Apr 28;13(16):2363-8. doi: 10.3748/wjg.v13.i16.2363. World J Gastroenterol. 2007. PMID: 17511039 Free PMC article.

4

Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture.

Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L. Cui J, et al. World J Gastroenterol. 2007 Nov 7;13(41):5432-9. doi: 10.3748/wjg.v13.i41.5432. World J Gastroenterol. 2007. PMID: 17907285 Free PMC article.

5

Survival advantages of multicellular spheroids vs. monolayers of HepG2 cells in vitro.

Li CL, Tian T, Nan KJ, Zhao N, Guo YH, Cui J, Wang J, Zhang WG. Li CL, et al. Oncol Rep. 2008 Dec;20(6):1465-71. Oncol Rep. 2008. PMID: 19020729

6

[Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells].

Liang X, Nan KJ, Li CL, Yao Y, Tian T, Wang SH. Liang X, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Dec;24(12):1140-2. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 19068194 Chinese.

7

[Functional study of the eukaryotic fluorescent expression vector of truncated lymphoid enhancer-binding factor 1 (LEF-1) gene in SW480 cells].

Wang SH, Tian T, Nan KJ. Wang SH, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Oct;29(10):2077-81. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19861271 Chinese.

8

p57: A multifunctional protein in cancer (Review).

Guo H, Tian T, Nan K, Wang W. Guo H, et al. Among authors: nan k. Int J Oncol. 2010 Jun;36(6):1321-9. doi: 10.3892/ijo_00000617. Int J Oncol. 2010. PMID: 20428755 Review.

9

PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.

Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP, Wang SH, Liang X, Lu CX. Tian T, et al. Oncol Rep. 2010 Jun;23(6):1593-600. doi: 10.3892/or_00000800. Oncol Rep. 2010. PMID: 20428814

10

PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.

Tian T, Nan KJ, Wang SH, Liang X, Lu CX, Guo H, Wang WJ, Ruan ZP. Tian T, et al. Carcinogenesis. 2010 Jul;31(7):1211-9. doi: 10.1093/carcin/bgq085. Epub 2010 Apr 29. Carcinogenesis. 2010. PMID: 20430845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters